ALVOW (ALVOW) Stock Price & Analysis
ALVOW (ALVOW) rose 0.00% to USD 0.3 as of June 10, 2026 at 05:51 UTC, according to Nexqual real-time market data.
ALVOW last closed at USD 0.3; the session ranged USD 0.22–0.3 on volume of 20 shares. Market capitalization is —, with a 52-week range of USD 0.22–0.3 (NGM). Source: Nexqual, June 10, 2026 at 05:51 UTC.
Key Statistics (as of June 10, 2026 at 05:51 UTC)
| Price | USD 0.3 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.3 |
| Open | USD 1.52 |
| Day Range | USD 0.22 – 0.3 |
| 52-Week Range | USD 0.22 – 0.3 |
| Volume | 20 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (ALVOW)
Nexqual's technical model rates ALVOW "STRONG SELL" based on 0 bullish and 6 bearish signals across 66 daily candles, as of June 10, 2026 at 05:51 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0.33) |
| MACD | 0 (negative) |
Analyst Ratings (ALVOW)
Wall Street analysts rate ALVOW "None", per Nexqual as of June 10, 2026 at 05:51 UTC.
| Consensus Rating | None |
|---|
Earnings (ALVOW)
| Revenue Estimate | $141.01M |
|---|
Source: Nexqual, June 10, 2026 at 05:51 UTC.
Financials & Fundamentals (ALVOW)
| Total Revenue | $562.04M |
|---|---|
| Revenue Growth (YoY) | -20.20% |
| Gross Margin | +61.53% |
| Operating Margin | +9.13% |
| Profit Margin | -14.36% |
| Current Ratio | 1.76 |
| Total Cash | $63.83M |
| Total Debt | $1.46B |
| Free Cash Flow | $-150.86M |
Source: Nexqual, June 10, 2026 at 05:51 UTC.
Financial Health Score (ALVOW)
Nexqual rates ALVOW's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 05:51 UTC.
| Growth | Strong — Revenue +20% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 62%, operating 9% |
| Balance Sheet | Mixed — $64M cash vs $1.46B debt |
| Cash Flow | Weak — FCF negative: -$151M, burning cash |
| Efficiency | Mixed — No data |
Ownership (ALVOW)
| Float | 114.09M |
|---|
Source: Nexqual, June 10, 2026 at 05:51 UTC.
Leadership (ALVOW)
ALVOW is led by Lisa Graver (age 53), Chief Executive Officer, per Nexqual as of June 10, 2026 at 05:51 UTC.
| Chief Executive Officer | Lisa Graver (age 53) |
|---|---|
| Founder & Executive Chairman | Vilhelm Robert Wessman (age 56) |
| Chief Financial Officer | Linda Jonsdottir (age 47) |
| Chief Operating Officer | Joseph E. McClellan (age 51) |
| Vice President of Investor Relations & Global Communications | Benedikt Stefansson |
Major Backers & Investors (ALVOW)
Notable institutional backers of ALVOW include Oaktree Capital Management LP, Linden Advisors LP, Jane Street Group, LLC, according to Nexqual as of June 10, 2026 at 05:51 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Oaktree Capital Management LP | 42.75% |
| Linden Advisors LP | 2.32% |
| Jane Street Group, LLC | 0.52% |
| Moore Capital Management, LP | 0.46% |
Source: Nexqual, June 10, 2026 at 05:51 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AREBW | American Rebel Holdings, Inc. | USD 0 | ▼ 81.82% |
| BIAFW | bioAffinity Technologies, Inc. | USD 0.16 | ▼ 47.05% |
| NNAVW | NextNav Inc. Warrant | USD 9.28 | ▲ 32.76% |
| REEWF | REEWF | USD 0.1 | ▲ 150% |
| QTEXW | QTREX Quantum Ltd. | USD 0.19 | ▼ 32.14% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:51 UTC. This page is informational and not investment advice.